ELF1 and central nervous system cancer: miR‐499a‐5p(+)+ELF1(−) group was compared with control group and miR‐499a‐5p(+)+ELF1(+) group, glioma cell proliferation, VM formation, migration and invasion of glioma cells were clearly decreased.